Digital Diabetes Management Market: Information by Type (Wearable Devices, Handheld Devices), Product & Services (Devices, Digital Diabetes Management Apps, Services), End User (Homecare, Academic & Research Institutes) — Global Forecast till 2027
ID: MRFR/HC/6058-HCR | February 2021 | Region: Global | 85 pages
Market Scenario
The global digital diabetes management market is accounted for USD 4,464.8 million in 2017 and expected to register ~ 23.7 % CAGR during the forecast period (2018–2023).
Digital diabetes management help diabetes patients to personalize and track diabetes by utilizing advanced paradigms of digital technologies through smart glucose meters and blood glucose tracking apps. Factor such as the rising prevalence of diabetes, increasing demand for self-care, technological advancements, rising geriatric population, and government initiative are expected to drive the growth of the market. Moreover, rising R&D spending and aggressive strategies adopted by the top players such as new product launches are contributing to the growth of the market. For instance, in October 2018, Novo Nordisk announced to introduce two connected insulin pens. However, the high cost associated with homecare devices and lack of awareness may hamper the growth of the market during the assessment period.
Segmentation
The global digital diabetes management market has been segmented on the basis of type, product and services, end user, and region.
On the basis of type, the market has been classified as wearable devices and handheld devices. The market, by product and service, has been segmented into devices, data management software and platforms, digital diabetes management apps, and services. The devices have been further segmented into smart glucose meters, smart insulin pens, continuous glucose monitoring systems, smart insulin pumps/closed loop systems & smart insulin patches. Moreover, digital diabetes management apps have been sub-segmented into weight & diet management apps and diabetes & blood glucose tracking apps. Based on end user, the market has been segmented into homecare, hospitals & specialty diabetes clinics, academic & research institutes, and others. The wearable devices segment is expected to hold the largest market share of the digital diabetes management market, by type, during the forecast period owing to regulatory approval of CGM system and technological advancement such as smart insulin patches. Also, homecare segment, by end user holds the largest market share in the global digital diabetes management market during the forecast period.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The digital diabetes management market in the Americas has further been segmented into North America and South America. Whereas, North American region has been further divided into the US and Canada.
The European digital diabetes management market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the Rest of Western Europe.
The digital diabetes management market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and Rest of Asia-Pacific. The digital diabetes management market in the Middle East & Africa has been segmented into the Middle East and Africa.
Regional Market Summary
Global Digital Diabetes Management Market Share, by Region, 2017 (%)
Source: MRFR Analysis
The Americas are likely to dominate the global digital diabetes management market owing to the wide acceptance of technologically advanced solutions such as closed-loop control systems, rising adoption of diabetes management remote online coaching services, connected diabetes management apps. Moreover, favorable reimbursement policies, raising awareness, government initiatives to promote digital health, and aggressive strategic adopted by players such as product launch, merger & acquisition, and partnership in this region also fueling the growth of digital diabetes management market. For instance, in November 2018, Nutrino has been acquired by Medtronic plc that strengthened Medtronic's portfolio in the digital diabetes management market.
The European market is expected to be the second-largest digital diabetes management market. The market growth in this region can be attributed to the government support for research & development and availability of funds for research.
Asia-Pacific is expected to be the fastest-growing digital diabetes management market during the forecast period owing to the rising number of the diabetes patient, increasing investments in healthcare and expansions by market players in the region. Moreover, countries such as India and China are considering the fastest growing region due to the presence of a huge patient population. Moreover, the government of these countries is open to adopting new technology and the best treatment option from a developed country. According to a research paper published by the National Center for Biotechnology Information (NCBI) in September 2016, diabetes will be the 7th leading cause of death by 2030.
The market in the Middle East & Africa is expected to account for the smallest share of the global digital diabetes management market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.
Key Players
Some of the key players in the global digital diabetes management market are Abbott Laboratories, Agamatrix, Inc., Ascensia Diabetes Care Holdings Ag., B. Braun Melsungen AG, Dariohealth Corporation, Dexcom, Inc., F. Hoffmann-La Roche, Glooko, Inc., Insulet Corporation, Lifescan, Inc., Medtronic PLC, Tandem Diabetes Care, Inc., Tidepool, and others
Global Digital Diabetes Management Market, by Type
- Wearable Devices
- Handheld Devices
Global Digital Diabetes Management Market, by Product and Service
- DevicesSmart Glucose Meters
- Smart Insulin Pens
- Continuous Glucose Monitoring Systems
- Smart Insulin Pumps/Closed Loop Systems & Smart Insulin Patches
- Data Management Software and Platforms
- Digital Diabetes Management AppsWeight & Diet Management Apps
- Diabetes & Blood Glucose Tracking Apps
- Services
Global Digital Diabetes Management Market, by End User
- Homecare
- Hospitals & Specialty Diabetes Clinics
- Academic & Research Institutes
- Others
Global Digital Diabetes Management Market, by Region
- Americas
- North America
- US
- Canada
- South America
- North America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Western Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- The Middle East & Africa
- Middle East
- Africa
Company Profiles
- Abbott Laboratories
- Agamatrix, Inc.
- Ascensia Diabetes Care Holdings Ag.
- Braun Melsungen AG
- Dariohealth Corporation
- Dexcom, Inc.
- Hoffmann-La Roche
- Glooko, Inc.
- Insulet Corporation
- Lifescan, Inc. (A Subsidiary of Johnson & Johnson)
- Medtronic PLC
- Tandem Diabetes Care, Inc.
- Tidepool
Intended Audience
- Medical devices companies
- Hospitals
- Research and development (R&D) companies
- Medical research laboratories
- Research and consulting firms
Frequently Asked Questions (FAQ) :
The global digital diabetes management market was valued at more than USD 4.4 billion in 2017.
The market is expected to exhibit a strong 23.7% CAGR over the forecast period from 2018 to 2023.
The growing prevalence of diabetes is the major driver for the market.
North America is the leading regional market, followed by Europe.
Leading players in the digital diabetes management market include B. Braun Melsungen, Abbott, F. Hoffman-La Roche, Agamatrix Inc., and Glooko, among others.
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
Chapter 3. Research Methodology
3.1. Introduction
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
Chapter 4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities
4.4. Challenges
4.5. Macroeconomic Indicators
4.6. Mega Trends & Assessment
Chapter 5. Market Factor Analysis
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
5.3. Investment Feasibility Analysis
5.4. Pricing Analysis
5.5. Regulatory Analysis
5.6. Reimbursement Scenario
Chapter 6. Global Digital Diabetes Management Market, by Type
6.1. Introduction
6.2. Wearable Devices
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3. Handheld Devices
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 7. Global Digital Diabetes Management Market, by Product and Service
7.1. Introduction
7.2. Devices
7.2.1. Smart Glucose Meters
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.2.2. Smart Insulin Pens
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.2.3. Continuous Glucose Monitoring Systems
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.2.4. Smart Insulin Pumps/Closed Loop Systems & Smart Insulin Patches
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3. Data Management Software and Platforms
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.4. Digital Diabetes Management Apps
7.4.1. Weight & Diet Management Apps
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.4.2. Diabetes & Blood Glucose Tracking Apps
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.5. Services
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 8. Global Digital Diabetes Management Market, by End User
8.1. Introduction
8.2. Homecare
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.3. Hospitals & Specialty Diabetes Clinics
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.4. Academic & Research Institutes
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.5. Others
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 9. Global Digital Diabetes Management Market, by Region
9.1. Introduction
9.2. Americas
9.2.1. North America
9.2.1.1. US
9.2.1.2. Canada
9.2.2. South America
9.3. Europe
9.3.1. Western Europe
9.3.1.1. Germany
9.3.1.2. France
9.3.1.3. Italy
9.3.1.4. Spain
9.3.1.5. UK
9.3.1.6. Rest of Western Europe
9.3.2. Eastern Europe
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Australia
9.4.5. South Korea
9.4.6. Rest of Asia-Pacific
9.5. Middle East & Africa
9.5.1. Middle East
9.5.2. Africa
Chapter 10. Company Landscape
10.1. Introduction
10.2. Market Share Analysis
10.3. Key Developments & Strategies
Chapter 11. Company Profiles
11.1. Abbott Laboratories
11.1.1. Company Overview
11.1.2. Product Overview
11.1.3. Financial Overview
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Agamatrix, Inc.
11.2.1. Company Overview
11.2.2. Product Overview
11.2.3. Financial Overview
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Ascensia Diabetes Care Holdings Ag.
11.3.1. Company Overview
11.3.2. Product Overview
11.3.3. Financial Overview
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. B. Braun Melsungen AG
11.4.1. Company Overview
11.4.2. Product Overview
11.4.3. Financial Overview
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Dariohealth Corporation
11.5.1. Company Overview
11.5.2. Product Overview
11.5.3. Financial Overview
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. Dexcom, Inc.
11.6.1. Company Overview
11.6.2. Product Overview
11.6.3. Financial Overview
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. F. Hoffmann-La Roche
11.7.1. Company Overview
11.7.2. Product Overview
11.7.3. Financial Overview
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. Glooko, Inc.
11.8.1. Company Overview
11.8.2. Product Overview
11.8.3. Financial Overview
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Insulet Corporation
11.9.1. Company Overview
11.9.2. Product Overview
11.9.3. Financial Overview
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Lifescan, Inc. (A Subsidiary of Johnson & Johnson)
11.10.1. Company Overview
11.10.2. Product Overview
11.10.3. Financial Overview
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
11.11. Medtronic PLC
11.11.1. Company Overview
11.11.2. Product Overview
11.11.3. Financial Overview
11.11.4. Key Developments
11.11.5. SWOT Analysis
11.11.6. Key Strategies
11.12. Tandem Diabetes Care, Inc.
11.12.1. Company Overview
11.12.2. Product Overview
11.12.3. Financial Overview
11.12.4. Key Developments
11.12.5. SWOT Analysis
11.12.6. Key Strategies
11.13. Tidepool
11.13.1. Company Overview
11.13.2. Product Overview
11.13.3. Financial Overview
11.13.4. Key Developments
11.13.5. SWOT Analysis
11.13.6. Key Strategies
11.14. Others
Chapter 12. MRFR Conclusion
12.1. Key Findings
12.1.1. From CEO’s Viewpoint
12.1.2. Unmet Needs of the Market
12.2. Key Companies to Watch
12.3. Predictions for the Digital Diabetes Management Industry
Chapter 13. Appendix
LIST OF TABLES
Table 1. Global Digital Diabetes Management Market Synopsis, 2020-2027
Table 2. Global Digital Diabetes Management Market Estimates and Forecast, 2020-2027 (USD Million)
Table 3. Global Digital Diabetes Management Market, by Region, 2020-2027 (USD Million)
Table 4. Global Digital Diabetes Management Market, by Type, 2020-2027 (USD Million)
Table 5. Global Digital Diabetes Management Market, by Product & Services, 2020-2027 (USD Million)
Table 6. Global Digital Diabetes Management Market, by End User, 2020-2027 (USD Million)
Table 7. North America: Digital Diabetes Management Market, by Type, 2020-2027 (USD Million)
Table 8. North America: Digital Diabetes Management Market, by Product & Services, 2020-2027 (USD Million)
Table 9. North America: Digital Diabetes Management Market, by End User, 2020-2027 (USD Million)
Table 10. US: Digital Diabetes Management Market, by Type, 2020-2027 (USD Million)
Table 11. US: Digital Diabetes Management Market, by Product & Services, 2020-2027 (USD Million)
Table 12. US: Digital Diabetes Management Market, by End User, 2020-2027 (USD Million)
Table 13. Canada: Digital Diabetes Management Market, by Type, 2020-2027 (USD Million)
Table 14. Canada: Digital Diabetes Management Market, by Product & Services, 2020-2027 (USD Million)
Table 15. Canada: Digital Diabetes Management Market, by End User, 2020-2027 (USD Million)
Table 16. South America: Digital Diabetes Management Market, by Type, 2020-2027 (USD Million)
Table 17. South America: Digital Diabetes Management Market, by Product & Services, 2020-2027 (USD Million)
Table 18. South America: Digital Diabetes Management Market, by End User, 2020-2027 (USD Million)
Table 19. Europe: Digital Diabetes Management Market, by Type, 2020-2027 (USD Million)
Table 20. Europe: Digital Diabetes Management Market, by Product & Services, 2020-2027 (USD Million)
Table 21. Europe: Digital Diabetes Management Market, by End User, 2020-2027 (USD Million)
Table 22. Western Europe: Digital Diabetes Management Market, by Type, 2020-2027 (USD Million)
Table 23. Western Europe: Digital Diabetes Management Market, by Product & Services, 2020-2027 (USD Million)
Table 24. Western Europe: Digital Diabetes Management Market, by End User, 2020-2027 (USD Million)
Table 25. Eastern Europe: Digital Diabetes Management Market, by Type, 2020-2027 (USD Million)
Table 26. Eastern Europe: Digital Diabetes Management Market, by Product & Services, 2020-2027 (USD Million)
Table 27. Eastern Europe: Digital Diabetes Management Market, by End User, 2020-2027 (USD Million)
Table 28. Asia-Pacific: Digital Diabetes Management Market, by Type, 2020-2027 (USD Million)
Table 29. Asia-Pacific: Digital Diabetes Management Market, by Product & Services, 2020-2027 (USD Million)
Table 30. Asia-Pacific: Digital Diabetes Management Market, by End User, 2020-2027 (USD Million)
Table 31. Middle East & Africa: Digital Diabetes Management Market, by Type, 2020-2027 (USD Million)
Table 32. Middle East & Africa: Digital Diabetes Management Market, by Product & Services, 2020-2027 (USD Million)
Table 33. Middle East & Africa: Digital Diabetes Management Market, by End User, 2020-2027 (USD Million)
LIST OF FIGURES
Figure 1. Research Process
Figure 2. Segmentation for Global Digital Diabetes Management Market
Figure 3. Segmentation Market Dynamics for Global Digital Diabetes Management Market
Figure 4. Global Digital Diabetes Management Market Share, by Type, 2020
Figure 5. Global Digital Diabetes Management Market Share, by Product & Services, 2020
Figure 6. Global Digital Diabetes Management Market Share, by End User, 2020
Figure 7. Global Digital Diabetes Management Market Share, by Region, 2020
Figure 8. North America: Digital Diabetes Management Market Share, by Country, 2020
Figure 9. Europe: Digital Diabetes Management Market Share, by Country, 2020
Figure 10. Asia-Pacific: Digital Diabetes Management Market Share, by Country, 2020
Figure 11. Middle East & Africa: Digital Diabetes Management Market Share, by Country, 2020
Figure 12. Global Digital Diabetes Management Market: Company Share Analysis, 2020 (%)
Figure 13. Abbott Laboratories: Key Financials
Figure 14. Abbott Laboratories: Segmental Revenue
Figure 15. Abbott Laboratories: Geographical Revenue
Figure 16. Agamatrix, Inc.: Key Financials
Figure 17. Agamatrix, Inc.: Segmental Revenue
Figure 18. Agamatrix, Inc.: Geographical Revenue
Figure 19. Ascensia Diabetes Care Holdings Ag.: Key Financials
Figure 20. Ascensia Diabetes Care Holdings Ag.: Segmental Revenue
Figure 21. Ascensia Diabetes Care Holdings Ag.: Geographical Revenue
Figure 22. B. Braun Melsungen AG: Key Financials
Figure 23. B. Braun Melsungen AG: Segmental Revenue
Figure 24. B. Braun Melsungen AG: Geographical Revenue
Figure 25. Dariohealth Corporation: Key Financials
Figure 26. Dariohealth Corporation: Segmental Revenue
Figure 27. Dariohealth Corporation: Geographical Revenue
Figure 28. Dexcom, Inc.: Key Financials
Figure 29. Dexcom, Inc.: Segmental Revenue
Figure 30. Dexcom, Inc.: Geographical Revenue
Figure 31. F. Hoffmann-La Roche: Key Financials
Figure 32. F. Hoffmann-La Roche: Segmental Revenue
Figure 33. F. Hoffmann-La Roche: Geographical Revenue
Figure 34. Glooko, Inc.: Key Financials
Figure 35. Glooko, Inc.: Segmental Revenue
Figure 36. Glooko, Inc.: Geographical Revenue
Figure 37. Insulet Corporation: Key Financials
Figure 38. Insulet Corporation: Segmental Revenue
Figure 39. Insulet Corporation: Geographical Revenue
Figure 40. Lifescan, Inc.: Key Financials
Figure 41. Lifescan, Inc.: Segmental Revenue
Figure 42. Lifescan, Inc.: Geographical Revenue
Figure 43. Medtronic PLC: Key Financials
Figure 44. Medtronic PLC: Segmental Revenue
Figure 45. Medtronic PLC: Geographical Revenue
Figure 46. Tandem Diabetes Care, Inc.: Key Financials
Figure 47. Tandem Diabetes Care, Inc.: Segmental Revenue
Figure 48. Tandem Diabetes Care, Inc.: Geographical Revenue
Figure 49. Tidepool: Key Financials
Figure 50. Tidepool: Segmental Revenue
Figure 51. Tidepool: Geographical Revenue
This table of content is tentative and subject to change as the research progresses.
Please Note: Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.
